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ABSTRACT
The chlorovirus Paramecium bursaria
chlorella virus 1 (PBCV-1) is a large dsDNA
virus that infects the microalga Chlorella
variabilis NC64A. Unlike most other viruses,
PBCV-1 encodes most, if not all, of the
machinery required to glycosylate its major
capsid protein (MCP). The structures of the four
N-linked glycans from the PBCV-1 MCP consist
of nonasaccharides, and similar glycans are not
found elsewhere in the three domains of life.
Here, we identified the roles of three virusencoded glycosyltransferases (GTs) that have
four distinct GT activities in glycan synthesis.
Two of the three GTs were previously annotated
as GTs but the third GT was identified in this
study. We determined the GT functions by
comparing the wild-type glycan structures from

PBCV-1 with those from a set of PBCV-1
spontaneous GT genes mutants resulting in
antigenic variants having truncated glycan
structures. According to our working model, the
virus gene a064r encodes a GT with three
domains:
domain
1
has
a
-Lrhamnosyltransferase activity, domain 2 has an
-L-rhamnosyltransferase activity and domain 3
is a methyltransferase that decorates two
positions in the terminal -L-rhamnose (Rha)
unit. The a075l gene encodes a xylosyltransferase that attaches the distal Dxylose (Xyl) unit to the L-fucose (Fuc) that is part
of the conserved N-glycan core region. Lastly,
gene a071r encodes a GT that is involved in the
attachment of a semiconserved element, -DRha, to the same L-Fuc in the core region. Our
1
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results uncover GT activities that assemble four
of the nine residues of the PBCV-1 MCP Nglycans.

Rha capped with two O-methyl groups. Two
monosaccharides, arabinose (Ara) and mannose
(Man), occur as non-stoichiometric substituents
resulting in the existence of four glycoforms (Fig.
1). Currently, structures of this type are unknown
elsewhere in the three domains of life.
The discovery of these glycans has
prompted our interest in viral glyco-related
genes. In this regard, 17 of the PBCV-1 genes
encode enzymes that manipulate sugars at
different levels (12) with six of them annotated as
encoding putative GTs: a064r (638 amino acids),
a111/114r (860 aa), a219/222/226r (677 aa),
a473l (517 aa), a546l (396 aa), and a075l (280
aa) (Table S1). In addition, a098r encodes a
functional hyaluronate synthase (13).
The genes encoding these GTs are
scattered throughout the genome of the virus and
PSORT predicted that most of these proteins are
soluble and located in the cytoplasm; a473l and
a219/222/226r are predicted to encode GTs with
six and nine transmembrane domains,
respectively, while the ngLOC program predicts
that A075L is located in the chloroplast, but only
at a 15% confidence level.
Thus, PBCV-1 encodes six GTs, a small
number when compared to the complexity of its
N-glycans. One solution to this paradox is that
one or more of the six GTs might have multiple
functional domains, making this restricted
repertoire of enzymes sufficient to synthesize
these structures. A second possibility is that some
other virus genes encode enzymes that do not
match GTs in the databases and so are overlooked
during the searches. Finally, we cannot exclude
the possibility that a host-encoded GT(s) could be
involved in the glycosylation process.
The protein encoded by gene a064r is of
special interest. This protein is coded by PBCV1 but not by any other chlorovirus where the
glycan structure is known (12), suggesting that
the a064r gene product is involved in the
synthesis of a structural motif of the N-glycan not
shared with the other chloroviruses (14-16). In
addition, several spontaneous mutants (or
antigenic variants) in a064r have been isolated
and their MCPs migrate faster on SDS-PAGE
compared to the MCP of PBCV-1, suggesting
that the glycan portion of the capsid protein is
altered.

Structural proteins of many viruses, such
as rhabdoviruses, herpesviruses, poxviruses and
paramyxoviruses, are glycosylated. Most virus
glycoproteins are N-linked to Asn via Nacetylglucosamine (GlcNAc), while less frequent
O-linked glycosylation also occurs (1). The
majority of the viruses studied to date use hostencoded glycosyltransferases (GTs) and
glycosidases located in the endoplasmic
reticulum (ER) and Golgi apparatus to add and
remove N-linked sugar residues from virus
glycoproteins either co-translationally or shortly
after translation of the protein (2-6). Posttranslational glycosylation can aid in protein
folding, protein stability, progression in the
secretory pathway and host-virus interactions.
One group of viruses that differs from the
above scenario is the plaque-forming
Chloroviruses (family Phycodnaviridae) that
infect certain isolates of chlorella-like green algae
(7). The viruses are divided into four groups
depending on the algal host infected:
chloroviruses that infect Chlorella variabilis
NC64A are referred to as NC64A viruses, those
that infect Chlorella variabilis Syngen 2-3 are
referred to as Osy viruses, those that infect
Chlorella heliozoae SAG 3.83 are referred to as
SAG viruses and those that infect Micractinium
conductrix Pbi are referred to as Pbi viruses. The
prototype chlorovirus Paramecium bursaria
chlorella virus (PBCV-1) is an NC64A virus (8)
and its 330 kb genome is predicted to encode 416
proteins (9). The major capsid protein (MCP or
Vp54) is coded by the gene a430l, and its gene
product has a predicted molecular weight of
48,165 Da, which increases to 53,790 Da due to
N-glycosylation at four positions (10, 11).
The predominant glycoform of the four
PBCV-1 N-glycans is a nonasaccharide (Fig. 1
WT) (11) with several unusual structural features
including: i) it is not linked to the typical Asn-X(Thr/Ser) sequon; ii) it is highly branched; iii) glucose (Glc) forms the N-linkage with Asn; iv)
fucose (Fuc) is substituted at all available
positions; and v) there are two rhamnose (Rha)
residues with opposite configurations plus an L2
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These PBCV-1 spontaneous mutants are
divided into six antigenic classes, each denoted
with a letter, based on their differential reaction
to five different polyclonal antibodies (12, 17).
Each class reacts specifically with one polyclonal
antibody preparation, except Class E, which
cross-reacts with Class A and B polyclonal
antibodies, suggesting that the phenotype of
Class E variants share some of the structural
features of the other two variants. Notably, all six
antigenic classes, except C, have a mutation in the
a064r gene (Table 1, Fig. 1).
For the reasons cited above and elsewhere
(12, 18), we hypothesize that the machinery for
PBCV-1 glycosylation is encoded primarily, if
not totally, by the virus. Furthermore,
glycosylation of the PBCV-1 MCP occurs in the
cytoplasm. The current study addresses two
issues related to PBCV-1 glycosylation. First, the
structures of the glycans attached to five PBCV1 antigenic variant MCPs are described. Second,
using genetic and glycan structure evidence, we
identify four of the putative GT activities
involved in the synthesis of the glycan(s).

Class D: structure of the glycan of the antigenic
variant P1L6
This virus is the most difficult to handle in
laboratory conditions because it is unstable and
tends to degrade during normal purification
procedures. This intrinsic fragility of the viral
particles hindered the obtaining of large amounts
of biomass. Thus, to avoid further losses during
chromatographic purification, the glycopeptide
mixture was studied directly omitting this
purification step.
Inspection of the 1H NMR spectrum of the
P1L6 glycan (Fig. 2, Fig. S1) showed two
anomeric signals at 5.61 and 5.28 ppm along with
a set of small signals at ca. 5.0 ppm, while the
other regions were crowded with signals from
peptides resulting from capsid protein digestion.
The structure of the glycan was determined
by combining the chemical data with the analysis
of the Heteronuclear Single Quantum Correlation
(HSQC) spectrum. GC-MS analysis of the
partially methylated and acetylated alditol
(PMAA) derivatives (not shown) indicated that
the sample contained a 2-linked Fuc, a terminal
Gal, a terminal Xyl, and a 3,4-linked Glc. The
HSQC spectrum (Fig. S1, Table S2) had four
anomeric resonances, and the overlap with the
spectrum of the PBCV-1 glycan, used as a
reference, permitted the identification of three of
the four residues. As for H (3,4-substitued Nlinked -Glc), E (terminal -Gal) and N (terminal
-Xyl), the 13C NMR chemical shifts were almost
identical to that of the reference glycan, with only
minor variations in the 1H NMR chemical shifts.
The remaining carbon resonances were assigned
to Fuc A, whose values differed from those of the
reference glycoside (19) due to glycosylation at
C-2. Thus, the N-linked glycan of P1L6 is a
tetrasaccharide, significantly truncated compared
to that of WT PBCV-1. It contained all the units
of the chloroviruses N-glycans present in the
conserved core region except the Xyl attached to
Fuc, referred to as the distal Xyl (14).

Results
Glycan structures from representatives of the
antigenic variants
The structures of the glycans from five
different classes (Class E variants were not
included in this study) were determined by
combining chemical (via GC-MS of the
appropriate derivatives) and NMR analyses,
using the consolidated approach developed for
PBCV-1 and the other chloroviruses (11, 14-16).
The 1H NMR spectrum of each variant (Fig. 2)
differed from that of wild-type virus PBCV-1,
supporting our hypothesis that the glycans were
different. Accordingly, the features of each
antigenic class will be described in increasing
order of the structural complexity of the glycans.
By convention, the monosaccharide residues
identified in each oligosaccharide are labeled
with the same (or a similar) letter used for the
analog unit of the glycan of the wild-type (WT)
virus PBCV-1 (Fig. 1 and Figs in the supporting
material). Unless mentioned otherwise, we have
focused on the major glycan structure of each of
the variants. In some cases, minor structures
made up less than 5-10% of the total sample.

Class C: structure of the antigenic variants E11
and E1L3
The identity of the E1L3 and E11 glycans
was deduced from the similarities between the
anomeric region of their proton spectra (Fig.
S2A) and by the coincidence of their HSCQ
spectra (Figs. S2B, S3). In addition, when
3
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compared to P1L6 HSQC (Fig. S1), both E11 and
E1L3 had one additional anomeric signal at 5.03
ppm.
As for E1L3, comparison of its HSQC
spectrum with those of PBCV-1 glycopeptides,
permitted the ready identification of several
monosaccharide units (Table S3): the N-linked
Glc H, the proximal Xyl N, and the Gal E. The
anomeric proton at 5.03 ppm was identified by
analyzing the other 2D NMR spectra including
correlation
spectroscopy
(COSY),
total
correlation
spectroscopy
(TOCSY)
and
transverse rotating frame Overhauser effect
spectroscopy (T-ROESY). These data revealed
that this resonance arose from a D-Rha unit linked
at O-3 of the Fuc unit A. Unlike the wild-type
glycan, this D-Rha was not further substituted
with the terminal Man G; therefore, it was
labelled F’ (and not F). Thus, E1L3 and E11
glycans are extended derivatives of P1L6 with the
D-Rha unit. Accordingly, the Fuc residue was
substituted at both O-2 and O-3 positions, in
agreement with the GC-MS linkage analysis of
this fraction (Fig. S2C).

antigenic class B, EPA1 and EPA2, consisted of
the conserved core region characteristic of all the
chloroviruses N-glycans described to date (1416) plus the semi-conserved element, the D-Rha
unit F’ (Fig. 1).
Class A: structure of the glycans of antigenic
variants P91, P9L1 and P9L10.
The glycopeptides from the three variants
of Class A shared a similar pattern of signals in
the anomeric region of the 1H NMR spectra,
although some marginal variations of their
relative intensities were noted (Fig. S5A).
Compared to Class B, the anomeric region of the
1
H NMR spectra of class A contained several
additional signals, and the structural elucidation
of these glycopeptides was performed by the
combined analysis of the 2D NMR spectra (Figs.
S5-7 and Tables S5-6) as discussed for the other
variants, and detailed in the Supporting
Information.
Indeed, P9L10 produces a family of four
glycopeptides, named P9L10A-D (Fig. S6), with
the distal Xyl M (or M”, see discussion in
Supporting Information) further elongated with
the -L-Rha unit. These four glycans differed in
the non-stoichiometric presence of two residues,
Man and Ara, as shown in Fig. S6.
As for the P9L1 glycopeptides, the HSQC
spectrum was almost superimposable on that of
P9L10. Some variations occurred for the
intensities of some signals as deduced by
comparing their proton spectra (Fig S5). In P9L1,
the intensities of E and E’ were comparable
suggesting that D-Rha was much less substituted
with Man compared to P9L10 glycopeptides.
Densities reporting the Ara (D unit) were not
detected, indicating that this unit was absent or
below the detection limit. Accordingly, P9L1
produced two main glycopeptides, analogues to
P9L10A and P9L10B (Fig. S6).
As for the glycopeptides of P91 (Fig. S7,
Table S6), most of the densities of its HSQC
spectrum (Fig. S7A, B) overlapped with those of
the P9L1 and P9L10 variants. Like P9L1, P91
variant lacks the Ara substitution to -L-Rha, and
produced two oligosaccharides equivalent to
P9L10A and P9L10B, as confirmed by analyzing
the homonuclear spectra (T-ROESY in Fig. S7C
and TOCSY in Fig. S7D). Importantly, these
spectra enabled the assignment of densities that

Class B: structure of the glycan of antigenic
variants EPA1 and EPA2
The 1H NMR (Fig. S4A) and HSQC (EPA2
reported as an example in Fig S4B) spectra of
EPA1 and EPA2 glycopeptides were almost
identical, and both displayed two anomeric
signals at 4.5-4.4 ppm, the region that in the
PBCV-1 wild-type glycan contains the two -Xyl
units M and N.
The units with anomeric signals at 5.63,
5.23, 5.04, 5.01 and 4.42 ppm were readily
attributed to the Fuc A, Gal E, D-Rha F’, Glc H
and to the proximal Xyl N, respectively, by
comparison with PBCV-1 glycan data. Notably,
the proton and carbon chemical shifts of Fuc A
(Table S4) indicated that this Fuc was substituted
at all the positions available, while D-Rha F’ was
not glycosylated.
Hence, NMR analysis focused on the
additional anomeric signal at 4.46 ppm. Studying
the connectivities from all the 2D NMR spectra
revealed that this signal belonged to a Xyl unit,
connected to O-4 of A as in the PBCV-1 WT
glycan, but not further substituted. Accordingly,
this Xyl was labeled M’. Overall, the NMR data
showed that the structure of the glycans of the
4
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escaped the HSQC detection due to the low
amount of the sample, including C-4 or C-5 of
M’’ (the putative position of these densities is
enclosed in a dotted circle in Fig. S7B).
The P91 HSQC spectrum contained some
additional signals, including a methyl group at
1
H/13C 3.56/62.4 ppm (Fig. S7A) and an anomeric
proton at 1H/13C 4.75/103.4 ppm (Fig. S7B).
NMR analysis of this new residue determined
that it was a -L-Rha, labelled as I”, that differed
from I and I’ because it was methylated at O-2
(Table S6). Methylation at O-2 did not induce
relevant variations in the chemical shift values of
all the other monosaccharides of the glycan,
except for H-4/C-4 values (1H/13C 3.71/80.5 ppm)
of the Xyl unit to which it was attached, named
M’”. For this new oligosaccharide (named P91,
Fig. S7) it was not possible to confirm if the DRha unit F was further elongated with Man G,
although this situation is the most plausible given
the abundance of this residue, similar to that of
Gal or Glc, as visible in the GC-MS profile of the
monosaccharide analysis (Fig. S5C). GC-MS
analysis also confirmed the presence of the
rhamnose unit methylated at O-2, and detected a
tiny amount of arabinose, that escaped the NMR
analysis due to its low abundance.

other protons of the unit, with H-6 at 1.26 ppm.
Thus, C was a Rha, and carbon chemical shift
values (Table S7) determined that it was configured at the anomeric center and not further
substituted. HMBC and T-ROESY spectra
showed that it was attached to O-2 of I, as in the
wild type virus, with the only difference that none
of its positions were further decorated with a
methyl group (Fig. 1).
As for other minor anomeric signals, it was
possible to assign only that at 1H/13C 5.15/101.8
ppm (Fig. S8), labeled B. It was an -Rha, that
differed from the most intense C because it was
attached to O-2 of L, the -Rha unit with D at O3.
Collectively, these data indicated that
CME6 produces a mixture of two N-glycans
(Figs. 1 and S8), identical to those described for
WT PBCV-1 with the only difference being that
the -L-Rha unit was not methylated.
Predicted PBCV-1 encoded genes involved in the
synthesis of its glycan
Based on the discovery that the structures
of the glycans from the five antigenic classes
were truncated versions of the glycan from the
WT PBCV-1 MCP and knowing that PBCV-1
already had several genes annotated as GTs (12,
Table S1), allowed us to predict the function of
some of them. These predictions were aided by
the fact that the complete genomes of a few
representatives of each of the four groups of
chloroviruses mentioned in the introduction
(NC64A, Osy, SAG, and Pbi viruses) have been
sequenced (7, 15) and the structures of the
glycan(s) attached to their MCPs have been
determined (14-16). The basic glycan core
structure is conserved in all of these viruses
(outlined in Fig. 1). Additional sugar decorations
occur on their respective core N-glycan structures
and present a molecular signature for each
chlorovirus. Therefore, knowledge of the glycan
structures and the presence/absence of genes
from the various groups of chloroviruses
contributed to our prediction of the role for two
of the PBCV-1 GTs. The features of each putative
GT are hereafter discussed in light of the
structural information of the glycans determined
in this study.

Class F: structure of the glycan of antigenic
variant CME6
Virus CME6 is the only variant isolated for
antigenic class F. Its proton and HSQC spectra
(Figs. 2 and S8) contained an additional anomeric
signal at 1H/13C 5.04/102.7 ppm (Fig. S8) when
compared to those of the P9L10 variant.
Comparison of the CME6 HSQC spectrum with
that of PBCV-1 readily identified most of the
residues, namely A, D-H, M and N, for which the
positions of all the proton and carbon resonances
were almost identical. Of note, units E’ or F’
described in class A variants were absent or
below the NMR detection limit indicating that DRha was fully substituted with Man. Minor
differences were found for the chemical shifts of
the residues I and L, the -L-Rha units 2- and 2,3linked, respectively.
Analysis focused on the signal C at 1H/13C
5.04/102.7 ppm, which had a weak H-1/H-2
correlation in the COSY spectrum (not shown),
while TOCSY spectrum read from H-2 (4.09
ppm) position identified the position of all the
5
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Class D mutants and the role of A111/114R in the
core glycan assembly/attachment
The four antigenic mutants in Class D
(P1L2, P1L3, P1L6 and P1L10) contain large
genomic deletions in similar locations that range
in size from 27.2 kb to 38.6 kb (genome
nucleotide locations: 12,407 to 39,576; 5,238 to
42,695; 2,190 to 40,797 and 7,698 to 39,722,
respectively), or collectively from genes a014r
through a078r (20). All of the chloroviruses (1416), as well as four of the five PBCV-1 antigenic
classes, have the conserved glycan core structure
composed of five monosaccharides (one unit of
D-Glc, D-Gal and L-Fuc, and two units of D-Xyl)
attached to the MCP (Fig. 1), plus D-Rha, the
semiconserved unit attached to Fuc.
Class D mutants are the only class with a
reduced core glycan structure (Fig. 1) and this
finding supported two conclusions: i) the core
structure is coded by a gene (or genes) located
outside of the collective region of the four large
deletion mutants; ii) the genes encoding the
attachment of the distal D-Xyl, the fifth unit of the
conserved core region, and the D-Rha, the
semiconserved unit of the core glycan, probably
lie in the region between a014r and a078r.
Accordingly, these two observations
suggest
that
the
protein
A111/114R
(NP_048459.2) is involved in the initiation
and/or attachment of four of the monosaccharides
in the conserved core glycan. Further evidence to
support this inference is that this gene and the
corresponding tetrasaccharide are present in all
the chloroviruses analyzed to date. Because the
chlorovirus core glycan is unique in nature, we
assume it must be at least partially, if not fully,
assembled/attached to the MCP by either a single
large viral protein or several smaller viral
proteins that are common to all the chloroviruses.
In PBCV-1, gene a111/114r is the only annotated
orthologous GT gene found outside of the regions
of the large deletion mutants described above and
which is present in all the other chloroviruses. In
addition, no MCP glycans smaller than the foursugar units have been found in any of the
chloroviruses (14-16) or in the PBCV-1 antigenic
variants (this manuscript).
The a111/114r gene, not including the
promoter region, consists of 2583 nts, which is
longer than any of the other annotated PBCV-1
GT genes. This gene encodes protein A111/114R,

which consists of 860 amino acids organized into
at least three domains; the second domain has
been annotated as a GT (9).
Because of the size of the a111/114r gene,
it is highly likely that mutations have occurred in
the gene over time, but such mutations are
probably lethal because no variant has been
isolated. The working model is that a mutation in
the a111/114r gene, and in the orthologous genes
from all of the chloroviruses, would result in the
absence of a glycan core attached to the MCP,
leading to the loss of a viable virus. This leads to
the conclusion that the unique four-sugar
structure is the minimal glycan required for
chlorovirus survival, although the way it
contributes to the viability of the virus is still
unclear. Certainly, the hydrophilic nature of the
glycans would help the virus to remain soluble,
and thus infective, in an aquatic environment.
Furthermore, as noted above, Class D variants are
unstable in the laboratory, suggesting that the
glycans may be important for MCP folding
and/or for the correct assemblage of the capsid.
Thus, all available evidence supports the
conclusion that A111/114R plays a key role in the
assemblage of part or all of the conserved core
oligosaccharide.
Class C mutants and the role of A071R
The glycans of the Class C mutants (Fig. 1)
differ from those of Class D because they have a
D-Rha attached to L-Fuc; however, like the Class
D mutants, the Class C mutants lack the distal DXyl and its attached sugars. The gene encoding
the enzyme involved in the attachment of D-Rha
to L-Fuc is located somewhere in the region
between genes a005r through a077l because the
Class D antigenic mutant P1L6, which lacks the
D-Rha, has no mutations in its genome other than
the large deletion that extends from genes a005r
through a077l. Therefore, the gene that encodes
the protein that performs this task must: i) lie
between genes a005r and a077l, ii) be found in
other NC64A viruses and OsyNE5, all of which
have a D-Rha attached to the L-Fuc, and iii) must
be absent in SAG and Pbi viruses because they
lack a D-Rha in that position. The only PBCV-1
gene that fits all of these requirements is a071r.
The protein encoded by this gene, A071R
(NP_048419.1), is of sufficient size (354 aa) to be
a GT although it has not been annotated as such.
6
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However, A071R does have sequence similar to
A064R domain 2, which also has not been
annotated as a GT but for which there is strong
evidence that it is a rhamnosyl GT (discussed
below).

Class B mutants and the role of A064R domain 1
(A064R-D1)
Class B antigenic variants lack the terminal
two L-Rha moieties (Fig. 1) but have the terminal
D-Xyl because they all have a functional a075l
gene; however, they have mutations that prevent
further elongation of the oligosaccharide chain.
Three Class B antigenic variants have been
genomically sequenced (EPA-1, EPA-2, and
P31), and all have mutations in the a064r gene,
which
encodes
the
protein
A064R
(NP_048412.1). This protein consists of 638
amino acids that are organized into at least three
functional domains of approximately 200 amino
acids each (Fig. 1). More specifically, all three
Class B antigenic variants have mutations in the
region of the a064r gene, that encodes domain 1
of A064R.
Previous studies annotated this domain as
a “fringe class” GT and hypothesized that the
DXD motif coordinated the phosphate of the
nucleotide sugar, presumably UDP-Glc, and a
divalent cation, Mn2+ (21, 22). The specificity of
this domain could not be inferred at that time
because the structure(s) of the N-glycans were
unknown, preventing any hypothesis about the
nature of the possible acceptor and donor
substrates.
Understanding the function of domain 1
was inferred by comparing the N-glycans of
Class B with those of Class A variants. These two
sets of N-glycans (Fig. 1) differ in the presence of
the -L-Rha unit I (or L), supporting the
hypothesis that the first domain of A064R
encodes a -L-rhamnosyltransferase that adds
this monosaccharide to O-4 of a Xyl unit M.
As a possible nucleotide donor, we
hypothesize that A064R-D1 uses UDP-Lrhamnose as substrate, while most prokaryotic
enzymes recognize the dTDP-bound sugar. This
difference can be explained by the fact that, in
contrast to GDP-L-fucose or GDP-D-Rha that can
be produced by virus derived enzymes (23), a
UDP-L-rhamnose biosynthetic pathway is not
encoded by the PBCV-1 genome. Thus, the
nucleotide activated L-rhamnose is presumably
synthesized by the chlorella host, using a typical
plant UDP-L-rhamnose biosynthetic pathway
(24).
This hypothesis is corroborated by both
docking studies (see below) and by biochemical

Class C mutants and the role of A075L
Class C antigenic variants also have
mutations that prevent the addition of the distal
D-Xyl, which is necessary before the addition of
the two L-Rha units. As noted above in the
discussion of the Class D large deletion mutants,
the protein that attaches the distal D-Xyl to the LFuc must be encoded by a gene that lies between
the genes a014r and a078l. The genetic evidence
supports the hypothesis that the protein A075L
(NP_048423.1) attaches D-Xyl to L-Fuc. This
protein was previously annotated as an exostosin
(Pfam database code PF03016.8), classified
within the GT47 family. Six Class C antigenic
mutants were genomically sequenced (E1L1,
E1L2, E1L3, E1L4, P41 and E11), and all six
have mutations in the a075l gene, but none of
them shared mutations in any of the other genes
that putatively encode GTs. The mutations in the
gene a075l were of three types: i) frameshift
mutations that cause premature termination of the
synthesis of the A075L protein; ii) nonsense
mutations that lead to premature termination of
A075L protein synthesis; and iii) in one case a
missense mutation in the initiator codon that
results in a failure to initiate A075L protein
synthesis. One of the Class C mutants, E11, is of
particular interest. E11 is derived from the Class
B antigenic mutant EPA-1, but the mutation
common with EPA-1 became masked when E11
acquired a second mutation, located in gene
a075l, which prevents the addition of the distal DXyl, the feature that distinguishes the Class C
mutants from those in Class B.
Additional evidence that supports the role
of A075L comes from seven other chlorovirus
species whose MCP glycan structures have been
determined (14-16). Even though these seven
chloroviruses infect four different algal hosts, all
of them have the same glycan core structure and
the same distal D-Xyl attached to the L-Fuc, as
does the wild type PBCV-1. These seven
chloroviruses all encode orthologs of the PBCV1 A075L protein.
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evidence that A064R domain 1 has this predicted
activity. 1

contain all the sugars that comprise the wild-type
glycan but lack the methyl groups at the O-2 and
O-3 positions of the terminal Rha units C or B
(Fig. 1). This finding confirms the role of the first
two domains of A064R, namely the first domain
attaches -L-Rha (I or L) to -Xyl M and domain
2 attaches the last Rha unit (C or B) to the -LRha.
While PBCV-1 encodes numerous DNA
methyltransferase genes, the only mutated
methyltransferase gene in CME6 is in the region
of gene a064r that encodes domain 3 (Fig. 1). The
best hit in a BLAST search of the wild type amino
acid sequence of domain 3 to the nucleotide
database
at
NCBI
was
to
2’-Orhamnosylmethyltransferases. Indeed, when the
rhamnosyl-methyltransferase
from
Mycobacterium smegmatis (25), was BLASTED
against the PBCV-1 protein database, the only hit
was to domain 3 of A064R (33% identity and
49% positive). Consequently, when a064r is
mutated in the third domain, the corresponding
N-glycan is not methylated at either the O-2 or O3 positions, suggesting that this methyltransferase
can perform a double methylation of the
monosaccharide. However, we cannot exclude
the possibility that domain 3 attaches only one
methyl
group
and
that
a
second
methyltransferase, yet to be identified, is required
to complete the full decoration of this Rha.
The mutant P91, a Class A variant,
provides additional support that domain 3 is a
rhamnosyl-methyltransferase. In the case of P91,
domain 3 of A064R is translated correctly
because the 27-nucleotide insertion in the second
domain of a064r maintains the correct reading
frame during its translation. Analysis of the P91
glycopeptide mixture detected a minor form with
-L-Rha methylated at O-2 (I”, Fig. S7). Thus,
domain 3 appears to be functional in P91, but it
lacks its natural substrate because the -L-Rha
unit C (or B) is not assembled at the end of the
glycan (see PBCV-1 structure in Fig. 1 and P91
glycan structure in Fig. S7) but there is a -L-Rha
for which it may have a reduced affinity.

Class A mutants and the role of A064R domain 2
Class A antigenic variants only lack the
terminal -L-Rha. Three variants of this antigenic
class have been genomically sequenced (P91,
EPA-11 and P9L1), and all of them lack
mutations in domain 1 of a064r, but all three have
mutations in domain 2 of this gene (Fig. 1), which
encodes a bacterial-derived protein of unknown
function. Furthermore, none of these three
variants has mutations in the gene that encodes
A075L. Thus, these three members of class A are
able to add the terminal D-Xyl and the -L-Rha to
the core glycan (Fig. 1). Two of the three mutants,
P9L1 and EPA-11, have nonsense mutations
(point mutations that become stop codons) that
lead to premature termination of translation. The
third mutant, P91, has a 27-nucleotide insertion
in the region of a064r that encodes domain 2. In
addition, the a064r gene of another class A
mutant, P9L10, was amplified by PCR and
sequenced. P9L10 acquired a nonsense mutation
in a064r that results in premature termination of
A064R near the N-terminus of domain 2;
consequently, the functions of both domain 2 and
3 are lost.
In summary, all of the class A variants
encode a functional domain 1 of A064R but are
unable to encode a functional domain 2. These
results are consistent with the glycan structure
results, which support the hypothesis that domain
2 is involved in the attachment of the second Rha
unit (C or B), the one with an  glycosidic
linkage and placed at O-2 of the first L-Rha unit
(I or L). For the reasons mentioned for A064RD1, our working hypothesis is that the second
domain of A064R accepts UDP-L-Rha as donor.
Class F mutant and the role of A064R domain 3
The antigenic variant CME6, whose
genome has been sequenced, is the only member
of antigenic class F (Table 1). The CME6 a064r
gene has a TC dinucleotide insertion at genome
position 36,276, which leads to premature chain
termination during translation of domain 3, while
the first two domains are unaffected.
Accordingly, the N-glycans of this variant
1

Modeling of UDP-Rha into the catalytic domain
1 of A064R

De Castro et al., work in progress
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Based on the evidence collected in this
study, A064R-D1 is predicted to use UDP-L-Rha
as the activated donor to synthetize the -L-Rha(1,4)--D-Xyl linkage. In a previous study (22),
this domain was cloned and crystallized and the
authors tested several nucleotide sugars, but not
UDP-L-Rha. The best affinity was found for
UDP-Glc. Therefore, a molecular modeling
approach was used to determine whether UDP-LRha is an acceptable substrate for this GT.
Docking methods are widely used to define
or predict the binding mode of a small ligand to a
receptor. Although these methods are efficient in
discriminating between binders and non-binders,
they are not particularly accurate and typically
cannot discriminate between substrates that differ
by less than one order of magnitude in affinity
(26). This is the case for the possible Rha/Glc
relative selectivity for A064R-D1. Subtle
differences originate from contributions of
hydrogen bonds and CH/ staking interactions.
Thus, a molecular dynamics (MD) approach was
used (27, 28). The structure deposited in the
protein database (PDB accession number 2P72)
contains UDP-Glc as substrate. Therefore, its
behavior was compared to that computed for the
UDP-L-Rha analogue.
In the X-ray structure, the donor UDP-Glc
is stabilized in the binding site by several
hydrogen bonds and Mn2+-oxygen interactions.
Specifically, upon ligand binding, the protein
undergoes a major conformational change, which
shifts Phe13 towards the uracil ring of UDP. Two
hydrogen bonds between the Phe13 backbone
atoms and the uracil ring are established. These
same hydrogen bond interactions are established
(compare Figs. 3A,D and 3B,E) in the model of
A064R-D1 bound to UDP-L-Rha and kept
throughout the entire simulation time (Fig. S9).
Similarly, the hydrogen bond network described
for the ribose moiety in the X-ray structure is also
maintained during the whole MD simulation
(Figs. 3B,E and S9). Specifically, the carbonyl
oxygen of Gly11 interacts with the OH2 of ribose,
while the NH of Ser79 is a hydrogen bond donor
to O3 of ribose. The hydrogen bond between the
carboxyl side chain of Asp78 and the OH3 of

2

ribose is established only in the last 25 ns of the
MD simulation (Fig. S9).
It has previously been described that His54
experiences a significant conformational change
upon UDP-Glc binding (Fig. 3C), suggesting a
key role for this residue as the required catalytic
base (22). Along this line, the MD simulation of
A064R-D1 with UDP-Rha clearly identifies a
stacking interaction among the histidine electron
cloud and the C-H moiety of the less polar face of
Rha (Fig. 3F). This CH/ interaction is stable in
all the MD simulations (Fig. S9). These findings
are in full agreement with the previous hypothesis
(22) about the role of N in His54, which
stabilizes the partial positive charge that develops
during the course of the reaction at the C1 atom.
In fact, the C1-N distance is only 4.5 Å on
average (Figs. 3F and S9). Finally, UDP-L-Rha is
kept in the catalytic site by a polar network
involving Arg57 and Pro149, which makes
hydrogen bonds with OH4 of the sugar ring (Figs.
3F and S9).
Next, the free energy of binding for both
UDP-L-Rha and UDP-Glc to A064R-D1 was
estimated by MM/GBSA methods (25, 26).
Interestingly, the computations predict that the
binding free energy for the A064R-D1/UDP-LRha complex is ca. 6 kcal/mol lower than that for
the A064R-D1/UDP-Glc analogue (Table 2), in
agreement with the prediction of the specificity of
this GT, and our preliminary experimental
results.2 Among the key components of the
binding free energy, UDP-Glc displayed the
largest electrostatic energy changes upon binding
(EELE) and also showed the largest polar
solvation energy (GSol). Thus, the computational
analysis strongly suggests that the major factor
favoring the binding of A064R-D1 for UDP-LRha over UDP-Glc is the lower polar character of
Rha with respect to Glc. These results are also in
agreement with the low polarity of the A064R-D1
binding site defined by Pro149, Phe148 and
Tyr150, which perfectly fit with the methyl
substituent of Rha through hydrophobic
interactions. Furthermore, we investigated why
the antigenic variant EPA-1 lacks the terminal LRha moieties, by docking the A064R_S79L
mutant with UDP-Rha substrate. The results of

De Castro, work in progress
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the analysis show that the bulky side chain of the
Leu79 entails the reorganization of the DXD
motif, with a consequent loss of Mn2+
coordination and most of the essential
interactions with the substrate. Specifically,
although the hydrogen bonds between the Phe13
and the uracil ring are preserved (Fig. 3G), the
hydrogen bond network for the ribose moiety is
completely abrogated (Fig. 3H). Even more,
His54 is now ~90° flipped precluding CH/
interactions (Fig. 3I). These structural data
provide an explanation for the observed truncated
oligosaccharide chain in EPA-1 antigenic variant.

least one or more other unknown PBCV-1
encoded proteins besides A111/114R is involved
in the assembly/attachment of the core glycan
structure to the MCP. Alternatively, a hostencoded enzyme(s) could also be involved in the
synthesis/attachment of the glycan core structure.
Viral encoded glycosylation is an
emerging concept in virology, and it is not
confined to virus PBCV-1. Other chloroviruses
possess the genetic tools to accomplish this task
and the same scenario probably occurs in other
taxonomically unrelated viruses. Indeed, bovine
herpesvirus and myxoma virus encode a -(1,6)GlcNAc- and a -(2,3)-sialyl-transferase,
respectively (29). In addition, we predict that
many of the giant viruses, characterized by large
particle size and very large genomes (30), will
encode at least some, if not all, of the enzymes
needed to glycosylate their glycoproteins.
The list of giant viruses includes all the
known members of the Mimiviridae and
Pandoraviridae families, along with Pithovirus
and Mollivirus sibericum (30), and many others
that are rapidly being discovered.
The giant viruses mentioned above differ
in morphology, genome size and physical size,
but they share a common trait in that their
genomes have several glycogenes, i.e., genes
encoding enzymes able to manipulate sugarnucleotides and GTs. Past work has demonstrated
that Mimivirus encodes three of the enzymes
needed to synthetize UDP-GlcNAc (31), along
with a functional pathway for UDP-Rha (32) and
for UDP-N-Acetyl-viosamine production (33,
34), and a functional glycogenin paralogue (35).
For many of the giant viruses, except for the
glycogenin of Mimivirus (35), the activities of the
putative glycogenes are yet to be determined.
If our prediction about giant viruses is
correct, investigations of these organisms will
provide the field of glycobiology with new
discoveries and may ultimately answer the central
question about what benefits these viruses have
by maintaining their own glycosylation
machinery through evolution.
Finally, interest in the new GTs described
in this report goes beyond the viral world, as they
have similarities with prokaryotic and eukaryotic
enzymes as exemplified by A064R-D1 for which
the best matches are with LgtA, a prokaryotic

Discussion
Unlike the great majority of viruses, the
chlorovirus PBCV-1 encodes most, if not all, of
the machinery to glycosylate its MCP. In this
study, the truncated glycan structures from a set
of PBCV-1 antigenic variants were determined.
These structures plus genetic evidence led to the
identification of four GT activities encoded by
three PBCV-1 genes: a064r, a071r and a075l,
and enabled us to predict their functions. The
a064r gene encodes a 638 amino acid protein
with three domains: domain 1 is a putative -Lrhamnosyltransferase, domain 2 is a previously
unknown GT, here defined as probably being an
-L-rhamnosyltransferase and domain 3 is a
methyltransferase that decorates one or both
positions of the terminal -L-Rha unit. Therefore,
we predict that the A064R protein produces the
disaccharide 2,3-diOMe--L-Rha-(1,2)--L-Rha
attached to O-4 of the distal Xyl unit (Fig. 4).
Gene a071r is predicted to encode a GT
that attaches a semiconserved -D-Rha to O-3 of
the L-Fuc located in the N-glycan core region
(Fig. 4). Gene a075r is predicted to encode the xylosyltransferase that attaches a D-Xyl unit to O4 of the same L-Fuc unit used as a substrate by
A071R (Fig. 4). Finally, the putative GT(s)
encoded by the a111/114r gene is predicted to be
involved in the synthesis of four of the five
residues composing the conserved glycan core
structure (Fig. 4), because it is one of the few
annotated GT encoding genes that is present in all
the chloroviruses. However, it is not known if
A111/114R transfers one or more of the sugars of
the tetrasaccharide described in variant P1L6
(Fig. 1). We cannot exclude the possibility that at
10
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protein, and with a
galactosyltransferase (22).

bovine

-(1,3)-

SPB-5 capillary column (Supelco, 30 m x 0.25
mm i.d., flow rate 0.8 mL min-1 using He as the
carrier gas). Electron impact mass spectra were
recorded with an ionization energy of 70 eV and
an ionizing current of 0.2 mA. The following
temperature program was used: 150°C for 5 min,
3°C/min up to 300°C, 300°C for 5 min.

Experimental procedures
Virus growth and glycopeptide isolation from
major capsid proteins
Antigenic variants of PBCV-1 (P9L10,
P9L1, P91, EPA-1, EPA-2, E11, E1L3, P1L6 and
CME6) were grown by infection of 4 L of
Chlorella variabilis NC64A cells and purified as
previously
described (36)
with some
modifications: lysates were exposed to 1% Triton
X-100 before two successive rounds of gradient
centrifugation in 10-40% sucrose. The virus was
treated with proteinase K (0.02 mg/ml) between
the sucrose gradients to remove external
contaminating proteins. The isolation of their
MCPs followed an established protocol (16).
Isolated amounts of MCP ranged from 0.2 mg to
1.5 mg. To isolate the glycopeptides, the MCP
from each variant was dissolved in water and
digested with proteinase K (Sigma code P6556).
The digestion process was conducted three times
over a time interval of 36 hr using proteinase K at
~20% by weight of the starting amount of the
MCP. The glycopeptide mixture was purified via
size exclusion chromatography as reported (11).
Each antigenic variant produced one main
glycopeptide fraction, eluting at approximately
50% of the column volume, with the exception of
virus E1L3, which produced two glycoforms. The
less abundant form was about 5-10% of the total
mixture; its proton spectrum was similar to that
of the WT virus and it was not investigated
further in this study. For the P1L6 virus variant,
due to the low amount of the virus available, the
purification step was omitted to avoid further
losses. This glycopeptide was analysed directly
via NMR spectroscopy; signals arising from the
non-glycosylated peptides did not hinder the
analysis of the glycan portion.

NMR acquisition conditions
All NMR experiments were carried out on
a Bruker DRX-600 spectrometer equipped with a
cryo-probe, calibrated with acetone used as an
internal standard (H = 2.225 ppm; C = 31.45
ppm) and recorded in D2O at 310 K (CME6, E11,
EPA1, EPA2, P9L1, P9L10 and E1L6), or at 316
K (P91) or at 323 K (E1L3) to shift the signal of
the residual water peak in order to minimise its
overlap with some of the glycopeptide signals.
The complete set of two-dimensional spectra
(DQ-COSY, TOCSY, T-ROESY, gHSQC and
gHMBC) were recorded for all glycopeptides,
except for PIL6, P9L1 and E11 for which the
gHSQC experiment was enough to establish the
structure of the glycan. The spectral width was set
to 10 ppm and the frequency carrier placed at the
residual HOD peak, suppressed by pre-saturation.
Two-dimensional spectra were measured using
standard Bruker software; for all the experiments,
512 FIDs of 2048 complex data points were
collected, 32 scans per FID were acquired for
homonuclear spectra and mixing times of 100 and
300 ms were used for TOCSY and T-ROESY
spectra acquisition, respectively. Heteronuclear
1
H-13C spectra were measured in the 1H-detection
mode, gHSQC spectrum was acquired with 30-60
scans per FID (depending on the abundance of the
sample), the GARP sequence was used for 13C
decoupling during acquisition; gHMBC scans
doubled those of gHSQC spectrum.
Bioinformatics
Geneious
11.0.5
software
(https://www.geneious.com, 38) was used to
deepen the genetic analysis of the variants to
identify other genes involved in glycosylation or
to define the nature of the mutation. The software
was used to assemble and map antigenic mutant
sequencing reads (total genome) to the PBCV-1
WT reference genome. The software allowed for
quick and easy identification of genetic variants
in the antigenic mutant viruses.

Glycopeptide chemical analysis
Partially methylated acetylated alditols,
and fully acetylated alditols were generated from
the purified glycoprotein (ca. 0.2 mg) or on the
glycopeptides according to published protocols
(37). Analyses of these derivatives was carried
out via GC-MS on an Agilent Technologies Gas
Chromatograph 6850A interfaced with a
selective Mass Detector 5973N equipped with a
11
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cutoff of 10 Å. A relaxation time of 2 ps was used
in order to equilibrate the entire system in each
step. The equilibrated structure was the starting
point for the final MD simulations at constant
temperature (300 K) and pressure (1 atm).
Molecular dynamics simulation without
constraints was recorded, using an NPT ensemble
with periodic boundary conditions, a cutoff of 10
Å, and the particle mesh Ewald method.
Coordinates and energy values were recorded
every 10000 steps (20 ps) for a total simulation
time of 100 ns and an ensemble of 5000 MD
frames. A detailed analysis of the MD trajectory
(for example, RMSD evaluation, kinetic and
potential energies, etc.) was accomplished using
the cpptraj module included in the Amber-Tools
16 package, and it is gathered in the Supporting
Information (Fig. S9). The structure of the GT
from antigenic variant EPA-1, GT A064R
D1_S79L mutant, in complex with the substrate
UDP-L-Rha was generated by mutagenesis tool
integrated in the PyMOL (The PyMOL
Molecular Graphics System, Version 2.0
Schrödinger, LLC) program. The generated
structure was minimized using the Amber16
program as previously described in this section.

MD simulation of UDP-Rha and UDP-Glc with
domain 1 of A064R.
The starting structure for MD simulation of
the GT A064R D1 in complex with the substrate
UDP-L-Rha was generated by replacing the Glc
unit of the UDP-Glc with L-Rha in the complex
with the enzyme (PDB code 2P72). The
structures of the UDP-Rha and UDP-Glc were
relaxed by energy minimization with a low
gradient convergence threshold (0.05) in 1000
steps with MM3* force field integrated in the
MacroModel program run under Maestro
(Schrödinger Release 2016-4, LLC, New York,
NY, 2016). The nucleotide moiety of the
minimized UDP-L-Rha and UDP-Glc were
superimposed on the UDP molecule in the
structure of A064R in complex with UDP (PDB
code 2P73). Partial charges of the ligands were
calculated using the Gaussian 09 package with
HF/6-31G(d) basis set. All molecular parameters
were converted using the Antechamber program
in the Amber16 package. The resulting structures
were used as starting points for molecular
dynamics simulation of 100 ns in explicit water
solvent, using the Amber16 program with the
protein.ff14SB force field parameters for protein
and the generalized amber force field gaff2 for
the sugar-nucleotide, whereas water.tip3p force
field was used for water and ions. The atomic
parameters for Mn2+ ion were defined according
to published data (39). The starting structures
were solvated in a 10 Å octahedral box of explicit
TIP3P waters, and counterions were added to
maintain electroneutrality. In order to fill all of
the protein cavities with water molecules, a
previous minimization for only solvent and ions
was made. To reach a low energy starting
structure, the entire system was minimized with a
higher number of cycles, using the accurate
steepest descent algorithm. The system was
subjected to two rapid molecular dynamic
simulations (heating and equilibration) before
starting the real dynamic simulation: i) 20 ps of
MD heating the whole system from 0 to 300 K,
using NVT (fixed number of atoms, N, a fixed
volume, V, and a fixed temperature, T) ensemble
and a cutoff of 10 Å, followed by ii) equilibration
of the entire system over 100 ps at 300 K using
NPT (fixed number of atoms, N, a fixed pressure,
P, and a fixed temperature, T) ensemble and a

MM/GBSA calculations.
Binding free energy analysis was
performed by applying the MM/GBSA
calculation. The molecular mechanic energies
combined with the generalized Born and surface
area continuum solvation method was applied to
the structure of UDP-L-Rha and UDP-Glc,
A064R-D1 and to the UDP-L-Rha/A064R-D1
and UDP-Glc/A064R-D1 complexes generated
from the MD simulations, as described in the
previous section. The receptor-ligand complexes
were energetically minimized by the MM/GBSA
method as implemented in the Sander program of
the Amber package. The atomic radii (set default
PBRadii mbondi2) were chosen for all GBSA
calculations.
For
the
ensemble-average
MM/GBSA rescoring, a MD trajectory was
obtained for both UDP-L-Rha/- and UDPGlc/A064R-D1 complexes. Snapshots of the
complex were extracted from the MD trajectory
at every 10 ps. Thus, the final binding free energy
is an average of the binding free energies of
10000 snapshots.
12
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Table 1: Genetic features of the 20 PBCV-1 antigenic variants. These variants are divided into six classes
depending on their reaction with polyclonal antibodies. Class E is not included in this study and omitted
in this table, because the members of this group cross-react with the antibodies selective for both Classes
A and B, suggesting an intermediate phenotype. All the antigenic classes, but C, have a mutation in
a064r, this gene encodes for a protein of 638 amino acids that includes three domains of ca. 200 amino
acids each (Fig. 1). The N-terminal domain 1 is a GT, domain 2 only matches bacterial proteins of
unknown function, domain 3 has a weak match with methyltransferases. The structure of the N-glycans
has been determined in this work (Fig. 1) for the antigenic variants typed in bold.
Antigenic variant
EPA-11
P9L1
P9L4
P9L7
P9L10
P91
EPA-1
EPA-2

P31

E11

E1L1
E1L2
E1L3
E1L4
P41

P1L2

P1L3

P1L6
P1L10

Antigenic Class A: mutation in the second domain of a064r (NP_048412.1)
Nonsense mutation (G→A) at nt position 932 in the gene; truncated protein (307 amino
acids)
Nonsense mutation (C→A) at nt position 704 in the gene; truncated protein (234 amino
acids)
Missense mutation (G→T) at nt position 1102 in the gene; amino acid substitution
(G368W)
Missense mutation (G→T) at nt position 1102 in the gene; amino acid substitution
(G368W)
Nonsense mutation (T→G) at nt position 669 in the gene; truncated protein (222 amino
acids)
Insertion of 27 nts after nt position 952 in the gene; insertion of 9 additional amino acids
Antigenic Class B: mutation in the first domain of a064r (NP_048412.1)
Missense mutation (C→T) at nt position 236 in the gene; amino acid substitution (S79L)
Frameshift mutation; single nt insertion of A after position 262; truncated protein (88 + 11
amino acids: frameshift results in 11 incorrect amino acids added before stop codon is
encountered)
Missense mutation (G→A) at nt position 362in the gene; amino acid substitution (G121E)
Antigenic Class C: no mutation in a064r (except E11); mutation in a075l (NP_48423.1:
280 amino acids)
Same mutation in a064r as EPA-1 (antigenic class B). Frameshift mutation in a075l; single
nucleotide addition at position 670; truncated protein (223 + 16 amino acids; frameshift
results in 16 incorrect amino acids added before premature stop codon is encountered).
Frameshift mutation; single nt deletion at position 666 in the gene; truncated protein (222
amino acids)
Nonsense mutation (G→A) at nt position 630 in the gene; truncated protein (209 amino
acids)
Missense mutation (A→T) in the initiator codon at nt position 1 in the gene; no protein
synthesis
Nonsense mutation (T→A) at nt position 659 in the gene; amino acid substitution (I220N)
Frameshift mutation single nt insertion of C after position 194 in the gene; truncated protein
(65 + 14 amino acids: frameshift results in 14 incorrect amino acids added before stop
codon is encountered)
Antigenic Class D: a064r fully deleted
Large deletion of 27,160 nts between genomic positions 12,320 and 39,480; the deletion
includes the 44 nts at the 3’ region of gene a014r through and including approximately half
of gene a075l.
Large deletion of 37,450 nts between genomic positions 4,970 and 42,420; the deletion
includes gene a009r through gene a078r (the 5’ breakpoint is between genes a007/008l and
a009r while the 3’ breakpoint is between genes a078r and a079r).
Large deletion of 38,642 nts between genomic positions 2,168 and 40,810; the deletion
includes the terminal one-sixth of gene a003r through the middle of gene a077l.
Large deletion of 32,060 nts between genomic positions 7,700 and 39,760; the deletion
includes approximately 60% of gene a011l through two-thirds of gene a075l.
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CME6

Antigenic Class F: mutation in the third domain of a064r (NP_048412.1)
Frameshift mutation; insertion of 2 nts at position 1320 in the gene; truncated protein (440
+ 10 amino acids: frameshift results in 10 incorrect amino acids added before stop codon
encountered)

Table 2. Calculated binding free energies (kcal/mol) for UDP-Rha (UDP-Rha) and UDP-Glc (UDP-Glc)
to A064R-D1. The binding free energy (Gbind) is decomposed into different energy terms: the gas-phase
interaction energy (∆Egas) between the receptor and the ligand is the sum of electrostatic (∆EELE) and van
der Waals (∆EVDW) interaction energies. The solvation free energy (∆Gsol) is divided into the polar (∆GGB)
and non-polar (∆GSurf) energy terms.
Substrate

EELE

EVDW

Egas

GSurf

GGB

GSol

Gbind

UDP-Rha

-200.21

-26.13

-226.35

-6.17

152.90

146.73

-79.63

UDP-Glc

-230.84

-24.86

-255.71

-7.11

188.85

181.74

-73.97

19

Virus encoded glycosyltransferases

Fig. 1. Glycan structures of WT and selected antigenic mutants of PBCV-1. In the WT, each
monosaccharide is denoted with the letter used during the NMR experiments, and residues inside the dotted
box define the conserved core region. The glycosidic linkage of non-stoichiometric substituents is denoted
with a broken line. Glyco1 and glyco2 are the most abundant glycoforms, both have Man. Glyco1 lacks
Ara and the units of the terminal L-Rha disaccharide are labelled as C and I. Ara is present in glyco2 and
the two L-Rha units are labelled B and L. Antigenic classes are labeled with a capital letter, (A-D and F)
and the structure of their glycans depends on the kind of mutation found in the genome, which in all cases,
except Classes C and D, occurs in the gene a064r. EPA1 (antigenic Class B) and E11 (antigenic Class C)
have identical mutations in domain 1 of a064r, but E11 has an additional mutation in gene a075l. P91 has
an additional glycoform with -L-Rha methylated at O-2, the letters used to label this oligosaccharide are
not reported due to crowding, and the structure is displayed in Fig. S7.
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Fig. 2. Anomeric region of the proton spectra of different variants, each representative of its antigenic class
(A-D and F). The proton spectrum of the WT virus PBCV-1 is given for comparison [with permission from
De Castro et al. (11)]. NMR spectra were recorded at 310 K except for P91 (316 K) and E1L3 (323 K).
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Fig. 3. Comparison of the active sites from the X-ray crystal structure of A064R-D1_WT:UDP-Glc (A-C),
a representative frame from MD simulation of A064R-D1_WT:UDP-L-Rha (D-F) and a minimized
structure of the mutant A064R-D1_S79L:UDP-L-Rha (G-I). (A,B,D,E) The binding mode of UDP is
essentially the same in either UDP-Glc crystal structure or UDP-L-Rha MD simulated structure. (C) and
(F): as expected, a different intermolecular interaction network is observed. For UDP-L-Rha, the His54
moves towards the Rha ring establishing CH- interactions with the sugar (green dotted lines). (G-I) The
mutation of the Ser79 by Leu dramatically alters substrate binding. Most of the intermolecular interactions
are abrogated. Hydrogen bonds are highlighted with red dotted lines, -stacking (in F) are highlighted with
green dotted lines. UDP-Glc, UDP-L-Rha, and key residues of the enzyme are shown as blue, red-purple,
and green sticks, respectively. Manganese is represented as purple sphere.
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Fig. 4. PBCV-1 glycan structure with the predicted GTs involved in the glycosidic bond formation. The
CAZY family fold is indicated in brackets next to the gene name (unk = unknown function, predicted as
GT in this study; nc: unclassified GT fold). Based on the data available, a111/114r is involved in the
formation of the tetrasaccharide enclosed in the inner grey box. Currently it is unknown if it catalyzes the
formation of one or more of the four glycosidic linkages enclosed. The larger grey box indicates the
monosaccharide units of the conserved N-glycan core region that is common to all other chloroviruses
examined to date. D1-, D2- and D3- refer to the three domains of protein A064R. Linkages for which the
corresponding GT is not identified yet are the non-stoichiometric substituents, Man and Ara, and have a
“?” next to them.
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Class A: structure of the glycans of the antigenic variants P91, P9L1 and P9L10
The glycopeptides from the three class A variants had a similar pattern of signals in the
anomeric region of the 1H NMR spectra, although some variations in their relative intensities were
observed (Fig. S5A). The resonances at ca. 5.2 ppm included two different protons in a ratio 1:2 in
P9L10 and P91 while 1:1 in P9L1; the resonances at  5.05 ppm included three signals in P9L10 and
P9L1 and only two in P91. This type of heterogeneity suggested that these viruses produced a mixture
of glycopeptides with one or more substituents present in non-stoichiometric amounts, as described
for the Man and Ara units in the N-glycans of the wild-type virus PBCV-1. The most abundant
sample, P9L10, was studied first and the structural information derived was used to interpret the
spectra of the glycopeptides from the other two variants.
Comparison of P9L10 HSQC spectrum with that of PBCV-1 readily identified a set of
equivalent residues, namely: A, D, E, F, G, N and H (Fig. 1, Fig. S5B); therefore, our analyses
focused on the remaining signals. In particular, the resonance at 5.03 ppm was analogous to F’
described for the antigenic classes B and C; thus, it was an un-substituted D-Rha. In the HMBC
spectrum, the F’ unit had a correlation with a signal at 1H/13C 4.23/87.4 ppm, identified as position
three of A’, a Fuc unit substituted at all positions available and with Gal unit E’ at O-2. Analysis of
the anomeric proton resonance at 4.46 ppm (Fig. S6), diagnostic of the distal Xyl unit, showed a
correlation with two different equatorial H-5 signals, at 4.34 and 4.25 ppm, suggesting that this signal
was a combination of two anomeric protons, labelled M and M”. Compared to M, proton and carbon
chemical shifts of M” were similar except for the equatorial H-5 and C-4 that in M” were at 4.25 and
79.7 ppm instead of 4.34 and 80.8 ppm, respectively. We assumed that the difference between M and
M” depended on the non-stoichiometric substitution of D-rhamnose with Man, and that M” was the
distal xylose unit the glycan devoid of Man residue (structures P9L10B and P9L10C in Fig. S6). The
region at 4.8-4.7 ppm contained four anomeric signals, all attributed to -L-Rha units (Figs. S5, S6),
which were labeled as I, I’, L and L’ (Table S5). The anomeric protons of I and I’ were at 4.73 and
4.79 ppm, respectively (Fig. S6), and both correlated with a H-2/C-2 at 4.06 (or 4.07)/72.0 ppm.
Analysis of the TOCSY spectrum from each H-2, determined the position of all the other protons of
the two units. The 1H and 13C values of these two units (Table S5) disclosed that they were not
glycosylated while the HMBC spectrum indicated that I was linked to O-4 of M while I’ to O-4 of
M”.
As for L and L’, H-2/C-2 and H-3/C-3 were found at 4.24 (or 4.23)/69.3 and 3.71/80.0 ppm,
respectively. These chemical shift values indicated that both units had a substituent at O-3, due to the
-glycosylation effect, which displaces C-3 to low fields with respect to the reference value (Bock &
Pedersen, 1983). L and L’ were linked to M and M”, respectively and both had an Ara unit D at OS-2

3, but unlike the PBCV-1 glycan, they were not elongated further with an -Rha unit. Indeed, P9L10
produces a family of four glycopeptides, named P9L10 A-D (Fig. S6), differing in the nonstoichiometric presence of two residues, Man and Ara, as shown in Fig. S6.
As for the P9L1 glycopeptides, the amount recovered after purification was low but enough to
record and compare the HSQC spectrum with that of P9L10. Their two spectra were very similar and
contained the same densities, with some variations occurring in their intensities as deduced by
comparing their proton spectra (Fig S5). Indeed, in P9L1 the intensities of E and E’ were comparable
suggesting that D-Rha was much less substituted with Man compared to P9L10 glycopeptides.
Densities reporting the Ara unit were not detected in the HSQC spectrum, indicating that this unit
was absent or below the instrumental detection limit. Accordingly, P9L1 produced two main
glycopeptides, analogues to P9L10A and P9L10B (Fig. S6).
The same strategy was applied to the glycopeptides of the P91 variant. Most of the densities of
its HSQC spectrum (Fig. S7A, B) overlapped with those of the P9L1 variant. Thus, the P91 variant
produced two oligosaccharides equivalent to P9L10A and P9L10B, as confirmed by analyzing the
homonuclear spectra (T-ROESY in Fig. S7C and TOCSY in Fig. S7D). Importantly, these spectra
enabled the assignment of densities that escaped the HSQC detection due to the low amount of the
sample, including C-4 or C-5 of M” (the putative position of these densities is enclosed in a dotted
circle in Fig. S7B).
The P91 HSQC spectrum contained some additional signals, a methyl group at 1H/13C 3.56/62.4
ppm (Fig. S7A) and a new anomeric proton at 1H/13C 4.75/103.4 ppm (Fig. S7B). NMR analysis of
the new residue determined that it was a -L-Rha, labelled as I”, that differed from I and I’ because
it was methylated at O-2 (Table S6); methylation at O-2 did not induce relevant variations in the
chemical shift values of all the other monosaccharides of the glycan, except for H-4/C-4 values of the
Xyl unit to which it was attached, named M’”, at 1H/13C 3.71/80.5 ppm instead of 3.75/80.8 ppm, as
in M of P9L10A or at 3.77/79.7 ppm as in M” of P9L10B. For this new oligosaccharide (named P91,
Fig. S7) it was not possible to confirm if the D-Rha unit F was further elongated with Man G, although
this situation is the most plausible because elongation with Man seems to be a dominant trait in this
variant of PBCV-1.
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Table S1. Features of putative glycosyltransferases of PBCV-1.
Accession no.
Size1 Location2
TM3
Putative GT
A064R
NP_048412
638
Cytoplasm
None
A071R6
NP_048419.1
354
Cytoplasm
None
A075L
NP_048423.1
280
Cytoplasm
None
A098R
NP_048446.1
568
Plastid
7
A111/114R
NP_048459.2
860
Cytoplasm
None
A219/222/226R NP_048569.3
677
Plastid
9-10
A473L
NP_048829.1
517
Plastid
6
A546L
NP_048902.4
396
Cytoplasm
None
1
Number of amino acids
2
Cellular localization determined using WoLF PSORT Prediction:
https://www.genscript.com/tools/wolf-psort
3
Number of transmembrane helice predicted using TMHMM v.2.0:
http://www.cbs.dtu.dk/services/TMHMM/
4
CAZy Carbohydrate Active Enzyme website: www.cazy.org
5
GTnc = glycosyltransferase family “not classified”
6
Determined in this work.

S-4

CAZy family4
GTnc5
Unknown
GT47
GT2
GT2
GT2
GT2
GTB

Table S2. 1H and 13C chemical shifts of glycopeptide from P1L6, the antigenic variant of Class D. Labels
used reflect those originally used for the glycan of the wild type virus PBCV-1. For structure, refer to figure
S1.

A
2--L-Fuc
D
t--D-Gal
H
3,4-D--Glc
N
t--D-Xyl

1

H
13
C
1
H
13
C
1
H
13
C
1
H
13
C

1
5.61
98.7
5.28
101.3
4.97
80.8
4.42
103.8

2
3.94
75.2
3.84
70.1
3.58
75.0
3.15
75.0

3
4.16
70.5
3.90
70.7
3.92
77.3
3.44
76.9

4
3.78
73.7
4.02
70.5
3.75
74.7
3.49
70.9

5 (5eq;5ax)
4.73
67.6
4.05
72.7
3.64
78.2
3.93;3.26
66.2

6;6’
1.20
16.6
3.73 x 2
62.5
3.96;3.89
60.1
---

Table S3. Proton and carbon chemical shifts obtained for E1L3 or E11 glycopeptides (class C antigenic
class). For structure, refer to figure S2 or S3.

A
2,3--L-Fuc
E
t--D-Gal
F’
t--D-Rha
H
3,4-D--Glc
N
t--D-Xyl

1

H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C

1
5.64
98.5
5.23
100.6
5.01
104.4
5.03
80.7
4.46
103.9

2
4.09
71.9
3.85
69.7
4.11
71.4
3.61
75.0
3.18
75.0

3
4.24
79.6
3.90
70.9
3.87
71.6
3.96
76.7
3.48
76.9

4
3.79
73.7
4.06
70.4
3.50
73.3
3.75
74.9
3.60
70.9

5 (5eq;5ax)
4.76
67.6
4.06
72.4
3.82
70.1
3.67
78.1
3.99;3.30
66.1

6;6’
1.23
16.2
3.75 x 2
62.2
1.32
18.0
3.96;3.85
60.7
---

Table S4. Proton and carbon chemical shifts obtained for EPA1 or EPA2 glycopeptides (class B antigenic
class). For structure, refer to figure S4.
1
2
3
4
5 (5eq;5ax) 6;6’
1
A
H
5.63
4.18
4.22
3.86
4.75
1.31
13
98.6
72.0
77.0
82.5
68.5
16.2
C
2,3,4--L-Fuc
1
E
H
5.23
3.82
3.86
4.03
4.03
3.74;3.71
13
100.2
69.6
71.0
70.4
72.5
62.3
C
t--D-Gal
1
F’
H
5.04
4.04
3.75
3.50
4.10
1.30
13
104.0
71.5
71.5
73.3
70.1
17.9
C
t--D-Rha
1
H
H
5.01
3.58
3.95
3.72
3.66
3.94;3.83
13
80.4
75.0
76.8
74.9
78.1
60.6
C
3,4-D--Glc
1
M’
H
4.46
3.39
3.45
3.66
4.03;3.23
-13
105.6
74.9
77.0
70.6
66.1
-C
t--D-Xyl
1
N
H
4.42
3.14
3.45
3.59
4.03;3.27
-13
104.1
74.9
77.0
71.0
66.1
-C
t--D-Xyl

S-5

Table S5. Proton and carbon chemical shifts obtained for the four P9L10 glycopeptides from antigenic class
A (structures reported in Fig. S6).
1
2
3
4
5 (5eq;5ax) 6;6’
1
A
H
5.62
4.18
4.20
3.87
4.76
1.30
13
98.6
72.0
76.3
82.3
68.5
16.3
C
2,3,4--L-Fuc
1
A’
H
5.64
4.16
4.23
3.87
4.76
1.30
13
98.6
72.0
77.4
82.3
68.5
16.3
C
2,3,4--L-Fuc
1
D
H
5.19
4.19
4.20
3.92
3.79;3.70
-13
100.3
77.6
74.6
83.1
62.9
-C
t--L-Araf
1
E
H
5.19
3.79
3.84
4.02
4.03
3.71 x 2
13
100.1
69.7
71.1
70.6
72.3
62.7
C
t--D-Gal
1
E’
H
5.23
3.83
3.85
4.02
4.03
3.71 x 2
13
100.3
69.7
71.1
70.6
72.7
62.7
C
t--D-Gal
1
F
H
5.06
4.19
3.87
3.58
4.11
1.30
13
103.5
71.4
79.8
72.4
70.5
18.2
C
3--D-Rha
1
F’
H
5.03
4.04
3.75
3.48
4.14
1.28
13
104.2
71.6
71.7
73.2
70.2
18.2
C
t--D-Rha
1
G
H
5.05
4.08
3.87
3.59
3.81
3.91;3.71
13
104.2
71.5
72.1
68.5
75.1
62.9
C
t--D-Man
1
H*
H
4.97
3.58
3.96
3.71
3.65
3.94;3.83
13
80.8
75.2
77.0
75.0
78.2
60.7
C
3,4--D-Glc
1
I
H
4.73
4.07
3.59
3.35
3.43
1.30
13
102.6
72.0
73.9
73.4
73.2
18.5
C
t--L-Rha
1
I’
H
4.79
4.06
3.59
3.35
3.38
1.30
13
102.1
72.0
73.9
73.3
73.2
18.5
C
t--L-Rha
1
L
H
4.74
4.24
3.71
3.45
3.43
1.32
13
102.6
69.3
80.0
71.7
73.2
18.6
C
3--L-Rha
1
L’
H
4.80
4.23
3.71
3.45
3.45
1.32
13
102.1
69.3
80.0
71.7
73.2
18.6
C
3--L-Rha
1
M
H
4.46
3.43
3.58
3.75
4.34;3.28
-13
105.4
74.8
75.7
80.8
65.7
-C
4--D-Xyl
1
M”
H
4.46
3.43
3.58
3.77
4.25;3.28
-13
105.4
74.8
75.7
79.7
65.4
-C
4--D-Xyl
1
N
H
4.42
3.15
3.45
3.59
4.03;3.28
-13
104.1
75.0
77.2
71.1
66.2
-C
t--D-Xyl
* N-linked Glc appeared as a group of two different anomeric signals at 4.97 and 5.02 ppm, probably due to the heterogeneity in the
peptide portion. Chemical shifts of the most abundant residue, H, are listed in the table; H’ differed from H only for the chemical
shift of the anomeric proton.

S-6

Table S6. Proton and carbon chemical shifts obtained for the glycopeptides of P91 variants (antigenic class
A). For simplicity, chemical shift values of the two glycans P9L10A and P9L10B are not repeated and listed
in Table S4, while this table reports the only values of the new units, I” and M’” (structure named as P91 is
reported in Fig. S7). 1H and 13C chemical shifts of the methyl group are 3.56 and 62.4 ppm, respectively. For
structure, refer to figure S7.
1
2
3
4
5 (5eq;5ax) 6
1
I”
H
4.75
3.78
3.59
3.27
3.40
1.30
13
103.4
81.7
73.9
73.6
73.2
18.5
C
t-2OMe--L-Rha
1
M”’
H
4.46
3.43
3.58
3.71
4.34;3.28
-13
105.4
74.8
75.7
80.5
65.7
-C
4--D-Xyl

Table S7. Proton and carbon chemical shifts obtained for the two CME6 glycopeptides (structures reported
in Fig. S8).

A
2,3,4--L-Fuc
B
t--L-Rha
C
t--L-Rha
D
t--L-Araf
E
t--D-Gal
F
3--D-Rha
G
t--D-Man
H
3,4--D-Glc
I
2--L-Rha
L
2,3--L-Rha
M
4--D-Xyl
N
t--D-Xyl

1

H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C
1
H
13
C

1
5.62
98.6
5.15
101.8
5.04
102.7
5.19
100.1
5.19
100.1
5.05
103.6
5.04
104.2
4.96
80.8
4.78
102.6
4.77
102.6
4.44
105.3
4.41
104.1

2
4.17
72.0
4.05
71.4
4.09
72.3
4.20
77.4
3.78
69.7
4.18
71.4
4.08
71.5
3.57
75.1
4.14
78.1
4.31
74.4
3.43
75.0
3.14
74.9

3
4.21
76.2
3.86
71.3
3.86
71.3
4.20
74.1
3.83
71.2
3.86
80.0
3.86
72.1
3.95
77.0
3.70
74.6
3.74
80.4
3.55
75.9
3.44
77.2
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4
3.88
82.0
3.43
73.4
3.43
73.4
3.91
83.0
4.00
70.6
3.56
72.3
3.60
68.5
3.70
74.9
3.38
73.4
3.47
72.4
3.74
81.0
3.59
71.1

5 (5eq;5ax)
4.74
68.5
4.10
4.10
4.10
69.9
3.78;3.71
62.8
4.02
72.6
4.12
70.5
3.81
75.1
3.65
78.2
3.47
73.6
3.49
73.5
4.33;3.25
65.8
4.03;3.27
66.2

6;6’
1.30
16.3
1.26
17.8
1.26
17.8
--3.71 x 2
62.6
1.30
18.2
3.91;3.71
62.9
3.93;3.83
60.7
1.30
18.5
1.32
18.6
-----

Supporting figures.

Fig. S1. Expansion of HSQC spectrum measured at 310 K for P1L6 glycopeptide (antigenic class D). Densities
are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1).
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Fig. S2. Collection of experimental data acquired for class C variants. A) Comparison of the anomeric region
of the proton spectra of E1L3 and E11 variants. B) Expansion of HSQC spectrum measured at 310 K for E1L3
glycopeptide. Densities are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1). C) GCMS chromatograms of the monosaccharide linkage analysis of E1L3; E11 gave equivalent results. *Impurities.
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Fig. S3. Expansion of HSQC spectrum measured at 310 K for E11 glycopeptide (antigenic class C). Densities
are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1).
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Fig. S4. Collection of experimental data acquired for class B. A) Comparison of the anomeric region of the
proton spectra of EPA1 and EPA2 variants. B) Expansion of HSQC spectrum measured at 310 K for EPA2
glycopeptide. Densities are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1).
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Fig. S5. Collection of experimental data acquired for class A. A) Comparison of the anomeric region of the
proton spectra of P9L10, P9L1, and P91 variants. B) Expansion of HSQC spectrum measured at 310 K for
P9L10 glycopeptide, equivalent to that of P9L1, which is therefore omitted. Densities are labeled with a letter
in analogy with that used for PBCV-1 glycans (Fig. 1). C) GC-MS chromatograms of the monosaccharide
composition as acetylated alditols of P91. Chemical analysis of the other two antigenic variants gave the same
results except for the 2O-Me-Rha unit that was missing. * Impurities.
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Fig. S6. Expansion of TOCSY (black) and COSY (cyan/red) spectra detailing the anomeric region of P9L10
glycopeptide mixture. P9L10 produces a mixture of four different glycopeptides, sketched on the top of the
figure, and that differ for the nonstoichiometric presence of Man G and Ara D, as occurs in PBCV-1 N-glycans.
This heterogeneity in substitution induces the splitting of many signals, as for the -Rha unit for which four
different anomeric signals exist (I, I’, L and L’). Notably, for -Rha, the H-1/H-2 correlation is too weak to
be detected in the COSY spectrum, while it is visible in the TOCSY, and two vertical dotted gray lines are
added to indicate that the densities I1,2 and L1,2 (or I’1,2 and L’1,2) do not align. P9L1 produces a mixture of
glycopeptides constituted from P9L10A and P9L10B species.
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Fig. S7. Collection of NMR data acquired for class A variant P91. A,B) expansions of HSQC spectrum
detailing the hydroxymethyl and carbinolic regions, respectively. Of note, the oligosaccharide P91 produces
only small amounts of P9L10B glycan therefore some of the correlations are missing, as occurs for H-4/C-4
M’’ and H-5/C-5 of M’’ densities, whose putative position is indicated with a dotted circle. C) T-ROESY
spectrum region detailing the correlations of the -Rha units, with that connecting H-1 of I’ pointing to H-4 of
M’’. D) TOCSY spectrum region detailing the complex pattern of the distal Xyl units M, M’’ and M’’’.
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Fig. S8. Expansion of HSQC spectrum measured at 310 K for CME6 glycopeptide (antigenic class F).
Densities are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1).
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Fig. S9. Distance evolution among the atoms involved in intermolecular interactions of A064R-D1: UDP-Rha
as function of simulation time.
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